share_log

MSD Acquisition Corp. (NASDAQ:MSDA) Short Interest Update

MSD Acquisition Corp. (NASDAQ:MSDA) Short Interest Update

美贊臣收購公司(納斯達克代碼:msda)空頭股數更新
Defense World ·  2022/10/18 02:32

MSD Acquisition Corp. (NASDAQ:MSDA – Get Rating) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totalling 3,900 shares, an increase of 30.0% from the September 15th total of 3,000 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 79,400 shares, the days-to-cover ratio is currently 0.0 days.

納斯達克收購公司(MSDA-GET Rating)在9月份見證了空頭股數的大幅增長。截至9月30日,空頭股數共有3900股,比9月15日的3000股增加了30.0%。該公司約0.0%的股票被賣空。根據日均成交量79,400股計算,目前天數與回補比率為0.0天。

Institutional Inflows and Outflows

機構資金流入和流出

A number of large investors have recently made changes to their positions in the stock. PenderFund Capital Management Ltd. acquired a new position in shares of MSD Acquisition in the 1st quarter valued at $77,000. Millennium Management LLC raised its stake in MSD Acquisition by 0.4% during the 2nd quarter. Millennium Management LLC now owns 1,569,986 shares of the company's stock worth $15,370,000 after buying an additional 6,455 shares during the period. OLD Mission Capital LLC acquired a new stake in MSD Acquisition during the 2nd quarter worth $110,000. UBS Group AG raised its stake in MSD Acquisition by 304,500.0% during the 1st quarter. UBS Group AG now owns 12,184 shares of the company's stock worth $119,000 after buying an additional 12,180 shares during the period. Finally, Sculptor Capital LP raised its stake in MSD Acquisition by 1.2% during the 1st quarter. Sculptor Capital LP now owns 1,015,990 shares of the company's stock worth $9,956,000 after buying an additional 12,192 shares during the period. Institutional investors and hedge funds own 52.53% of the company's stock.

一些大型投資者最近改變了他們在該股的頭寸。PenderFund資本管理有限公司在第一季度收購了價值7.7萬美元的MSD收購股票,獲得了新的頭寸。千禧管理有限責任公司在第二季度將其在MSD收購中的持股增加了0.4%。Millennium Management LLC現在擁有1,569,986股該公司股票,價值15,370,000美元,在此期間又購買了6,455股。舊使命資本有限責任公司在第二季度收購了價值11萬美元的MSD收購的新股份。瑞銀集團(UBS Group AG)在第一季度將其在MSD收購中的持股比例提高了304,500.0%。瑞銀集團(UBS Group AG)在此期間又購買了12,180股,目前持有12,184股該公司股票,價值119,000美元。最後,Sculptor Capital LP在第一季度將其在MSD收購中的持股增加了1.2%。在此期間,雕塑家Capital LP又購買了12,192股,現在擁有1,015,990股該公司股票,價值9956,000美元。機構投資者和對衝基金持有該公司52.53%的股票。

Get
到達
MSD Acquisition
MSD收購
alerts:
警報:

MSD Acquisition Price Performance

MSD收購性價比

MSDA stock opened at $9.91 on Tuesday. The business's fifty day moving average is $9.88 and its 200-day moving average is $9.83. MSD Acquisition has a twelve month low of $9.68 and a twelve month high of $10.17.

週二,MSDA的股票開盤報9.91美元。該業務的50日移動均線切入位為9.88美元,200日移動均線切入位為9.83美元。MSD收購的12個月低點為9.68美元,12個月高位為10.17美元。

About MSD Acquisition

關於MSD收購

(Get Rating)
(獲取評級)

MSD Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the technology and media sectors. The company was incorporated in 2021 and is based in New York, New York.

MSD收購公司沒有重要的業務。擬與技術和媒體領域的一家或多家企業進行合併、換股、資產收購、購股、重組或類似的業務合併。該公司成立於2021年,總部設在紐約。

Recommended Stories

推薦故事

  • Get a free copy of the StockNews.com research report on MSD Acquisition (MSDA)
  • Biogen's Stock Pullback Offers a Second Chance
  • Pitch a Tent in Camping World Stock
  • Fisker is Entering a Critical Stage That Could Reward Investors
  • The Bottom Is In For JPMorgan Chase & Co.
  • The Institutions May Cap Gains In Steel Dynamics
  • 免費獲取StockNews.com關於MSD收購的研究報告(MSDA)
  • Biogen的股票回調提供了第二次機會
  • 在露營世界股票中搭起帳篷
  • 菲斯克正在進入一個關鍵階段,這可能會給投資者帶來回報
  • 摩根大通的日子不好過了。
  • 這些機構可能會限制鋼鐵動力領域的收益

Receive News & Ratings for MSD Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSD Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

接收MSD收購日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對MSD收購和相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論